Cost-utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial.

PLoS One · 2020 · PMC6988929 · PMID 31995558

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

CM: €430.39 [CI: 0.00 to 4,841.48]), although these large differences—mainly due to a few patients being hospitalized in the TM group, as opposed to none in the CM group—did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.